French Health Authority Warns Men Under 30 To Avoid Moderna Jab

Francesco Abbruzzino, The Uncensored Report, LLC

The bad news for Moderna just keeps coming.

In the wake of a weak earnings report that sent Moderna shares cratering last week, French health authorities have just released a new advisory recommending that people under 30 don’t get the Moderna vaccine, recommending that they choose the Pfizer-BioNTech jab instead.

The decision draws on recently released data showing that the risk of heart inflammation from Pfizer’s jab “appears to be around five times lesser…compared to Modera’s spikevax jab”, per an opinion published by the HAS.

Cases of myocarditis mostly manifest within 7 days of vaccination, typically after the second dose has been given. Most patients who experience side effects are typically men under the age of 30, according to the HAS, which cited research studies.